Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy.

Journal: Urologic oncology
Published Date:

Abstract

PURPOSE: Differences exist concerning when and how to perform lymph node dissection (LND) during radical prostatectomy due to lack of high-grade evidence to its safety and efficacy. We aimed to compare readmission rates between limited and extended LND during open radical prostatectomy (ORP) and robot-assisted radical prostatectomy (RARP).

Authors

  • Stavros I Tyritzis
    Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Ulrica Wilderäng
    Division of Clinical Cancer Epidemiology, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Αnna Wallerstedt Lantz
    Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institute.
  • Gunnar Steineck
    Division of Clinical Cancer Epidemiology, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Oncology and Pathology, Division of Clinical Cancer Epidemiology, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Jonas Hugosson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Anders Bjartell
    Department of Urology, Skåne University Hospital, Lund University, Lund, Sweden.
  • Johan Stranne
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Eva Haglind
    Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Nils Peter Wiklund
    Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institute; Department of Urology, ICAHN School of Medicine, Mount Sinai, New York, USA.